Why the study?
The prevalence and long-term consequences of baseline cardiac geometry differences, and whether sex and racial differences in these findings explain outcome disparities in patients undergoing PCI for ACS, were ill-defined.
Does cardiac geometry variation according to sex explain differences in outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
Does cardiac geometry variation according to sex explain differences in outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
Females undergoing PCI for ACS have higher rates of eccentric hypertrophy and worse 1-year outcomes than males, though the geometric differences do not fully explain the outcome disparity.
Introduction The prevalence and long-term consequences of differences in baseline cardiac geometry (as a result of hypertension) in patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) are ill-defined. The primary purpose of this study was to clarify whether there were differences among sexual and racial groups in echocardiographic findings reflecting cardiac geometry and adaptation in patients undergoing PCI for ACS and whether this could explain the differences in outcomes seen between these groups. Material and methods We analyzed 1-year follow-up data from a single institution, a retrospective, observational study that enrolled 1,153 patients who presented with ACS and were treated with PCI, for whom echocardiographic data were available. Results Normal, concentric hypertrophy, and eccentric hypertrophy in males vs. females were observed as follows: 29% vs. 19% (p = 0.001), 25% vs. 31% (p = 0.02), and 8% vs. 14% (p = 0.004), respectively. The primary endpoint of all-cause death (n = 89, 7.7%) occurred in 48 (10.5%) females and in 41 (8.2%) males, p = 0.03. Major adverse cardiac events and bleeding (MACE-B – all-cause death, non-fatal myocardial infarction, stroke or hospitalization for bleeding) was higher among women than men (21.6% vs. 13.5%, p = 0.0002). Males with eccentric hypertrophy (EH) had similar MACE-B outcomes as females with EH 1-year post-PCI (29% vs. 32%, respectively, p = 0.77). Conclusions Females undergoing PCI for ACS are at higher risk for worse outcomes because they are more likely to express the eccentric hypertrophy phenotype; however, it did not account for the difference in adverse outcomes observed between sexes.
No takes yet. Share an insight, caveat, or question.
Ha et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: